Bactericidal antibodies against hypervirulent

Hypervirulent MenC strains MenACWY-CRM conjugate vaccine MenC-CRM conjugate vaccine cc11/cc334 clonal complexes outbreak

Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
04 05 2021
Historique:
pubmed: 17 12 2020
medline: 6 7 2021
entrez: 16 12 2020
Statut: ppublish

Résumé

An increase in invasive meningococcal disease (IMD) incidence was observed in Tuscany in 2015/2016, mainly due to hypervirulent clonal complex (cc) 11 strains. In a

Identifiants

pubmed: 33325757
doi: 10.1080/21645515.2020.1833578
pmc: PMC8078732
doi:

Substances chimiques

Antibodies, Bacterial 0
MenACWY 0
Meningococcal Vaccines 0
Vaccines, Conjugate 0

Banques de données

ClinicalTrials.gov
['NCT00667602', 'NCT01345721']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1442-1449

Références

BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Mol Biol Evol. 2006 Feb;23(2):254-67
pubmed: 16221896
Vaccine. 2015 Aug 26;33(36):4414-21
pubmed: 26187262
Vaccine. 2009 Jun 24;27 Suppl 2:B112-6
pubmed: 19464093
BMC Genomics. 2014 Dec 18;15:1138
pubmed: 25523208
Euro Surveill. 2016;21(12):
pubmed: 27035155
Vaccine. 2005 Mar 18;23(17-18):2222-7
pubmed: 15755600
Clin Diagn Lab Immunol. 2005 Aug;12(8):970-6
pubmed: 16085915
Vaccine. 2018 Jul 5;36(29):4222-4227
pubmed: 29895504
J Exp Med. 1969 Jun 1;129(6):1307-26
pubmed: 4977280
Clin Vaccine Immunol. 2010 Jul;17(7):1055-65
pubmed: 20463105
J Infect Dis. 2006 Mar 15;193(6):821-8
pubmed: 16479517
JAMA. 2008 Jan 9;299(2):173-84
pubmed: 18182599
Clin Vaccine Immunol. 2009 Jul;16(7):969-77
pubmed: 19474264
Wellcome Open Res. 2018 Sep 24;3:124
pubmed: 30345391

Auteurs

Marzia Monica Giuliani (MM)

Preclinical Evidence Generation, GSK, Siena, Italy.

Alessia Biolchi (A)

Preclinical Evidence Generation, GSK, Siena, Italy.

Pavitra Keshavan (P)

Clinical Research and Development, GSK, Siena, Italy.

Maria Moriondo (M)

Department of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.

Sara Tomei (S)

Preclinical Evidence Generation, GSK, Siena, Italy.

Laura Santini (L)

Preclinical Evidence Generation, GSK, Siena, Italy.

Elena Mori (E)

Preclinical Evidence Generation, GSK, Siena, Italy.

Alessandro Brozzi (A)

Data Science and Digital Innovation, GSK, Siena, Italy.

Margherita Bodini (M)

Data Science and Digital Innovation, GSK, Siena, Italy.

Francesco Nieddu (F)

Department of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.

Silvia Ricci (S)

Department of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.

Thembile Mzolo (T)

Biostat and Statistical Programming, GSK, Amsterdam, The Netherlands.

Marco Costantini (M)

Biostat and Statistical Programming, GSK, Siena, Italy.

Chiara Azzari (C)

Department of Health Sciences, University of Florence and Meyer Children's University Hospital, Florence, Italy.

Michele Pellegrini (M)

Clinical Research and Development, GSK, Siena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH